Decoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling

Area of Science:

• Reproductive biology
• Developmental biology
• Molecular medicine

Background:

• Maternal pregestational diabetes is a significant risk factor for congenital malformations, affecting 6-10% of infants.
• The prevalence of diabetes in women of reproductive age is rising, posing a growing public health concern for birth defects.
• Neural tube defects and congenital heart defects are the most common birth defects linked to maternal diabetes.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying maternal diabetes-induced birth defects, focusing on neural tube defects.
• To identify key signaling pathways and cellular processes involved in diabetic embryopathy.
• To explore potential therapeutic targets for preventing diabetes-related congenital malformations.

Main Methods:

• Utilized animal models of maternal diabetes to study embryonic development under hyperglycemic conditions.
• Investigated the role of oxidative stress, reactive oxygen species, and antioxidant capacity in diabetic embryopathy.
• Analyzed the activation of signaling intermediates including protein kinase C (PKC), apoptosis signal-regulating kinase 1 (ASK1), c-Jun-N-terminal kinase (JNK1/2), and caspase pathways.
• Examined the involvement of the unfolded protein response and endoplasmic reticulum (ER) stress in diabetic embryopathy.

Main Results:

• Hyperglycemic conditions in embryos lead to increased oxidative stress and impaired antioxidant defenses.
• Maternal diabetes activates proapoptotic signaling pathways (PKC, ASK1, JNK1/2, caspase) and ER stress in developing embryos.
• A reciprocal relationship exists between JNK1/2 activation and ER stress in diabetic embryopathy.
• Genetic deletion or inhibition of key genes (Prkc, Ask1, Jnk1/2) and ER stress ameliorates neural progenitor apoptosis and prevents NTD formation.
• Cell membrane stabilizers and antioxidant supplements demonstrated preventive effects against diabetes-induced birth defects.

Conclusions:

• Maternal diabetes induces birth defects through oxidative stress, apoptosis, and ER stress pathways in the embryo.
• Targeting specific molecular pathways like ASK1 and JNK1/2, as well as ER stress, offers potential therapeutic strategies.
• Interventions such as antioxidant supplements and cell membrane stabilizers show promise in preventing diabetic embryopathy.
• Understanding these molecular mechanisms provides a basis for developing novel treatments for pregnancy complications associated with maternal diabetes.